Investing
Edison, GlaxoSmithKline Drop into Wednesday's 52-Week Low Club
Published:
Last Updated:
December 6, 2017: Here are four stocks trading with heavy volume among 121 equities making new 52-week lows in Wednesday’s session. On the NYSE decliners led advancers by about 3 to 2 and on the Nasdaq, decliners led advancers by more than 9 to 5.
OSI Systems Inc. (NASDAQ: OSIS) dropped 36% Wednesday to post a new 52-week low of $53.80 after closing at $84.07 on Tuesday. The 52-week high is $96.64. Volume was around 9 million, around 6 times the daily average of about 155,000. Short seller Muddy Waters called OSI “rotten to the core” in a new report this morning.
Edison International (NYSE: EIX) posted a new 52-week low of $67.83 Wednesday, down 3% after closing at $70.00 on Tuesday. The 52-week high is $83.38. Volume was about 7.8 million, more than four times the daily average of around 1.9 million shares. The auto parts maker spun out of Delphi Automotive this morning to become a standalone engine and components company. The rapidly spreading wildfire in Southern California has knocked out a portion of the company’s Southern California Edison service.
Cemex SAB de CV (NYSE: CX) dropped about 1.8% Wednesday to post a new 52-week low of $7.16 after closing at $7.29 on Tuesday. The 52-week high is $10.37. Volume was around 7 million, about 20% below the daily average of around 9.5. The Mexico-based cement company had no specific news.
GlaxoSmithKline plc (NYSE: GSK) dropped about 1% Wednesday to post a new 52-week low of $34.52 after closing at $34.86 on Tuesday. The stock’s 52-week high is $44.54. Volume of around 4.8 million was about equal to the daily average. The company’s HIV drug is being challenged by a potentially better drug from competitor Gilead Sciences.
Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance—and SmartAsset’s made it easier than ever for you to connect with a vetted financial advisor.
Here’s how it works:
Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.